Treatment Pathway
Treatment of Giardiasis
Giardiasis is a common intestinal infection caused by the protozoan parasite Giardia lamblia, transmitted through contaminated water or food. It presents with chronic diarrhoea, bloating, and malabsorption, and is treated with metronidazole or tinidazole.
WHO Global Antimicrobial GuidelinesIDSA (Infectious Diseases Society of America)NICE (UK)ECDC (European Centre for Disease Prevention)Surviving Sepsis Campaign
Giardiasis is a common intestinal infection caused by the protozoan parasite Giardia lamblia, transmitted through contaminated water or food. It presents with chronic diarrhoea, bloating, and malabsorption, and is treated with metronidazole or tinidazole.
First-Line Treatment Principles
- ✓Identify pathogen and antimicrobial sensitivities before initiating targeted therapy
- ✓De-escalate antimicrobial spectrum as soon as culture/sensitivity results available
- ✓Source control: drainage of abscesses, removal of infected catheters/prosthetics
- ✓Empirical antibiotics: cover likely pathogens based on clinical syndrome and local resistance patterns
- ✓Adhere to minimum effective duration to reduce resistance selection
Medications Used in Giardiasis
Non-Pharmacological Management
- •Infection prevention: hand hygiene, vaccination, insect bite prevention (malaria/dengue/Lyme)
- •Isolation precautions for highly contagious or drug-resistant organisms
- •Nutritional support: adequate protein and calorie intake during infectious illness
- •Rest and adequate hydration during acute illness
- •Vector control for vector-borne diseases (mosquito nets, repellents, chemoprophylaxis for travel)
- •Contact tracing for notifiable diseases (TB, meningococcal, sexual infections)
Treatment Goals
🎯Microbiological eradication: negative cultures, resolution of pathogen-specific markers
🎯Clinical cure: resolution of fever, inflammatory markers, and organ dysfunction
🎯Prevention of complications: abscess formation, septicaemia, chronic infection
🎯Minimise antimicrobial resistance development through appropriate stewardship
🎯Return to full functional capacity and prevention of recurrence
Monitoring Parameters
- ◆Temperature, heart rate, respiratory rate, and blood pressure: 4-hourly in hospital
- ◆CRP, procalcitonin: inflammation markers to guide treatment response and de-escalation
- ◆Blood cultures: before antibiotics if systemic infection suspected; repeat if deterioration
- ◆Organ function: LFTs, renal function, FBC — especially with prolonged therapy
- ◆Antimicrobial drug levels (vancomycin, aminoglycosides) to optimise dosing and prevent toxicity
- ◆Clinical response at 48–72h: reassess empirical therapy if no improvement
Escalation Criteria
- →Sepsis/septic shock: immediate IV broad-spectrum antibiotics within 1 hour; ICU admission
- →Clinical deterioration at 48–72h despite appropriate antibiotics → reassess diagnosis, obtain cultures, consider resistant organisms
- →Drug-resistant organism identified → infectious disease specialist review
- →Immunocompromised host: lower threshold for escalation; consider uncommon pathogens (fungal, mycobacterial)
Special Populations
Immunocompromised: HIV, transplant, chemotherapy patients need broader empirical coverage and lower threshold for invasive investigation
Pregnancy: many antibiotics restricted (fluoroquinolones, tetracyclines, aminoglycosides) — seek specialist guidance
Children: weight-based dosing; higher suspicion for unusual organisms (meningococcal in adolescents, Haemophilus in unvaccinated)
Elderly: impaired immune response; higher risk of drug toxicity; atypical presentations (confusion as only sign)
Clinical Insights
Not sure about your symptoms?
Our AI Symptom Checker analyses your symptoms and suggests the most likely diagnoses — including relevant treatment pathways.
Use AI Symptom Checker →